High Blood Pressure Medicine as Lung Cancer Treatment?

An experimental high blood pressure medicine called Angiontensin-(1-7) has shown initial promise as a potential lung cancer treatment according to Patricia E. Gallagher, Ph.D., and E. Ann Tallant, Ph.D, researchers from Wake Forest University.

Their data, recently published in the journal Cancer Research, showed that mice treated with Angiotensin-(1-7) had tumors shrink by about 30% in the same amount of time it took for tumors in untreated mice to approximately double in size.

The drug, which is still in the early phases of investigation, is very similar to ACE Inhibitors, one of the commonly prescribed high blood pressure drugs.